Fuzi-lizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease by Blocking TLR4/MyD88/TRAF6 Signaling Pathway
Ying Zhang(ZheJiang Institute For Food and Drug Control), Zhaohong Shi(Jiangsu University)
Cited by 1
Related Papers
The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis
|Nature|1992|1.3k
lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer
|Scientific Reports|2015|212
Rv0901 from <i>Mycobacterium tuberculosis</i>, a Possible Novel Virulent Gene Proved through the Recombinant <i>Mycobacterium smegmatis</i>
|Japanese Journal of Infectious Diseases|2009|13
Sijunzi, Lizhong, and Fuzilizhong Decoction Alleviate Nonalcoholic Fatty Liver Disease through Activation of PPAR Pathway
|Evidence-based Complementary and Alternative Medicine|2020|5